The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that are consistent with early signs of SARS-CoV-2 infection in this high-risk population by automatically (and securely) transferring this information to health care providers. The primary aim of this study is to determine the feasibility, ease of use, and perceived utility of this app to monitor symptoms and health risk behaviors among cancer patients currently receiving chemotherapy.
A total of 500 treatment-seeking males and females will be asked to complete daily monitoring
of symptoms via smartphone app. Those who screen positive for COVID-19 will be triaged to
emergency or non-emergency medical treatment and will receive a study supplied device to
measure their oxygen level and heart rate and be instructed in the device's use. They will be
prompted to enter vital signs data (such as oxygen level) daily (and as indicated by changes
in status) and questions from the app will change to assess the severity of COVID-19 related
symptoms and inform changes in level of care, to emergency or non-emergency medical
management as indicated by self-reporting. The proposed study will assess the impact of
heightened symptom and vital sign monitoring on the early identification of severe
manifestations of COVID-19 in this high-risk population (Aim 2). It is hypothesized that this
will significantly improve COVID-19 related morbidity and mortality compared to the national
and international rates currently reported in the literature.
Other: mHealth Assessments
Daily symptom tracker
Inclusion Criteria:
1. Demonstrate > 6th grade English literacy level (i.e., phone based EMAs require >6th
grade literacy)
2. Present for care at the Stephenson Cancer Center at the University of Oklahoma Health
Sciences Center
3. Are currently receiving systemic chemotherapy by intravenous infusion or by orally
delivered medication
4. Are greater than or equal to 18 years of age
5. Are willing and able to complete surveys on their personal smartphone or a study
provided smartphone
6. Are willing and able to provide informed consent
Exclusion Criteria:
- None
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States